TROG Cancer Research
Members Login   CQMS Login

Subspecialty Working Parties

The primary role of the Breast, Genitourinary, Lung and Head, Neck and Skin working parties is to advise the TROG Scientific Committee (TSC) on current trials and projects in the subspecialty research portfolio, on any gaps in research activities, on new research concepts including the scientific merit of the proposal and on the research priorities to be adopted by TROG. Please see the Working Party Terms of Reference for more detailed information.

The Subspecialty Working Parties will represent radiation oncology, medical physics, radiation therapy, statistics, consumers and other appropriate disciplines (e.g. medical oncology, allied health).

If you are interested in join a working party group please complete an Expression of Interest form.   

Breast Working Party

Chair: Boon Chua

Group contact:
Tamica Humby

TROG Central Office
Phone: +61 2 4014 3905

Genitourinary Working Party

Chair: David Pryor 

Group contact:
Courtney Hill
TROG Central Office
Phone: +61 2 4014 3911

Head, Neck and Skin Working Party

Chair: June Corry

Group contact:
Patrick Wheeler
TROG Central Office
Phone: +61 2 4014 3903

Lung Working Party

Chair: Fiona Hegi-Johnson

Group contact:
Brita Lehmann
TROG Central Office
Phone: +61 2 4014 3912


TROG explores advances in radiotherapy that influence clinical practice worldwide.

Latest News

  • 15 Jan 2020

    _ src="/sitefiles/trogcomau/fbp_0378_large.jpg" /> new research by the university of new south wales (unsw), presented at the clinical oncology society of australia’s (cosa) annual scientific meeting (asm) found that increased use of radiation therapy for prostate cancer patients c...

  • 13 Sep 2019

    trog cancer research will work with clinicians at townsville hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new mri linac technology to benefit cancer patients. img src="/sitefiles/trogcomau/tro_trog_cancer_resear...

  • 09 Sep 2019

    TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.  The workshop facilitated by Ms Alison Evans, Hea...

  • 03 Sep 2019

    trog cancer research are proud to announce that we have two new additions to the trog cancer research board of directors. joining our team is professor annette haworth and denis byron. appointed as a non-radiation oncology director, annette is an accredited medical physicist wh...

  • 12 Feb 2019

    a new clinical trial by trog cancer research has shown for the first time that a new radiotherapy technique produced greater survival rates in early stage inoperable lung cancer patients, compared to conventional radiation treatment. the trog 09.02 chisel study aimed to investigate if...

  • 29 Jan 2019

    results from australia’s and new zealand’s biggest cancer trial have identified the best treatment regime for men suffering from newly-diagnosed aggressive but localised prostate cancer. the radar study, run through trog cancer research, compared the use of hormone treatment (longer v...